文献速递慢性肾脏病遗传性与小管间质肾病

常染色体显性多囊肾病的肾脏能量代谢与囊肿负荷:一项初步研究

Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study.
PubMed 文献 · Am J Kidney Dis · 2024-04-15

本横断面初步研究纳入20例ADPKD成人及11例正常体重对照,采用11C-乙酸PET/CT评估肾脏氧化代谢与灌注,高胰岛素-正葡萄糖钳夹评估胰岛素敏感性。结果显示ADPKD患者肾皮质灌注、全肾氧化代谢及胰岛素敏感性均降低,且与身高校正总肾体积(HTKV)负相关。

要点

  • ADPKD患者即使肾功能保留,肾皮质灌注和全肾氧化代谢已显著降低。
  • HTKV与皮质灌注、全肾氧化代谢及胰岛素敏感性均呈负相关。
  • 11C-乙酸PET/CT可无创评估ADPKD肾脏能量代谢改变。

核心结论

  • ADPKD成人在肾功能保留时已出现肾灌注和肾脏氧化代谢受损,且与囊肿负荷和肾脏增大相关。

研究设计与样本

  • 横断面初步研究,纳入20例ADPKD成人(年龄31±6岁,65%女性,eGFR 103±18 mL/min/1.73m2)和11例正常体重对照(年龄25±3岁,45%女性,eGFR 113±15 mL/min/1.73m2)。

主要发现

  • 与正常体重对照相比,ADPKD患者M/I比值更低(0.586±0.205 vs 0.424±0.171 [mg/kg lean/min]/(μIU/mL),P=0.04)。
  • ADPKD患者肾皮质灌注中位数更低(1.93 [IQR 1.80-2.09] vs 0.68 [IQR 0.47-1.04] mL/min/g,P<0.001)。
  • ADPKD患者全肾氧化代谢中位数更低(0.17 [IQR 0.16-0.19] vs 0.14 [IQR 0.12-0.15] min-1,P=0.001)。
  • HTKV与皮质灌注(r=-0.83,P<0.001)、全肾氧化代谢(r=-0.61,P<0.001)及M/I(r=-0.41,P=0.03)呈负相关。

临床怎么用

  • 对于ADPKD患者,即使eGFR正常,也应关注肾脏灌注和代谢异常,PET/CT可作为研究性评估手段。

局限性

  • 样本量小且为横断面设计,无法推断因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: In this pilot study, we hypothesized that autosomal dominant polycystic kidney disease (ADPKD) is characterized by impaired kidney oxidative metabolism that associates with kidney size and cyst burden. STUDY DESIGN: Cross-sectional study. SETTING & PARTICIPANTS: Twenty adults with ADPKD (age, 31±6 years; 65% women; body mass index [BMI], 26.8 [22.7-30.4] kg/m2; estimated glomerular filtration rate [eGFR, 2021 CKD-EPI creatinine], 103±18mL/min/1.73m2; height-adjusted total kidney volume [HTKV], 731±370mL/m; Mayo classifications 1B [5%], 1C [42%], 1D [21%], and 1E [32%]) and 11 controls in normal weight category (NWC) (age, 25±3 years; 45% women; BMI, 22.5 [21.7-24.2] kg/m2; eGFR, 113±15mL/min/1.73m2; HTKV, 159±31mL/m) at the University of Colorado Anschutz Medical Campus. PREDICTORS: ADPKD status (yes/no) and severity (Mayo classifications). OUTCOME: HTKV and cyst burden by magnetic resonance imaging, kidney oxidative metabolism, and perfusion by 11C-acetate positron emission tomography/computed tomography, insulin sensitivity by hyperinsulinemic-euglycemic clamps (presented as ratio of M-value of steady state insulin concentration [M/I]). ANALYTICAL APPROACH: For categorical variables, χ2/Fisher's exact tests, and for continuous variables t tests/Mann-Whitney U tests. Pearson correlation was used to estimate the relationships between variables. RESULTS: Compared with NWC individuals, the participants with ADPKD exhibited lower mean±SD M/I ratio (0.586±0.205 vs 0.424±0.171 [mg/kg lean/min]/(μIU/mL), P=0.04), lower median cortical perfusion (1.93 [IQR, 1.80-2.09] vs 0.68 [IQR, 0.47-1.04] mL/min/g, P<0.001) and lower median total kidney oxidative metabolism (0.17 [IQR, 0.16-0.19] vs. 0.14 [IQR, 0.12-0.15] min-1, P=0.001) in voxel-wise models excluding cysts. HTKV correlated inversely with cortical perfusion (r: -0.83, P < 0.001), total kidney oxidative metabolism (r: -0.61, P<0.001) and M/I (r: -0.41, P = 0.03). LIMITATIONS: Small sample size and cross-sectional design. CONCLUSIONS: Adults with ADPKD and preserved kidney function exhibited impaired renal perfusion and kidney oxidative metabolism across a wide range of cysts and kidney enlargements. FUNDING: Grants from government (National Institutes of Health, Centers for Disease Control and Prevention) and not-for-profit (JDRF) entities. TRIAL REGISTRATION: Registered at ClinicalTrials.gov with study numbers NCT04407481 and NCT04074668. PLAIN-LANGUAGE SUMMARY: In our study, we explored how a common genetic kidney condition, autosomal dominant polycystic kidney disease (ADPKD), relates to kidney metabolism. ADPKD leads to the growth of numerous cysts in the kidneys, which can impact their ability to work properly. We wanted to understand the kidneys' ability to process oxygen and blood flow in ADPKD. Our approach involved using advanced imaging techniques to observe kidney metabolism and blood flow in people with ADPKD compared with healthy individuals. We discovered that those with ADPKD had significant changes in kidney oxygen metabolism even when their kidney function was still normal. These findings are crucial as they provide deeper insights into ADPKD, potentially guiding future treatments to target these changes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Bjornstad P, Richard G, Choi YJ, et al. Kidney Energetics and Cyst Burden in Autosomal Dominant Polycystic Kidney Disease: A Pilot Study. Am J Kidney Dis. 2024. PMID: 38621633. doi:10.1053/j.ajkd.2024.02.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。